MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

Faith writes guides, how-tos, and roundups on the latest Android games and apps for Android Police. You'll find her writing about the newest free-to-play game to hit Android or discussing her paranoia ...

Program Length: Minimum of 24 months Tuition: Approximately $69,588 per year. Additional fees apply. View tuition details. Degree/Certificate: M.S.D. Application Deadline: Rolling admission This ...

RIYADH, Saudi Arabia: Lifera, a PIF Company, announces the signing of a non-binding Memorandum of Understanding (MOU) with MSD (also known as Merck & Co., Inc., Rahway, N.J., USA in the U.S. and ...

Merck & Co (MSD) has broken ground on its new pharmaceutical manufacturing Centre of Excellence in Virginia, US, amid looming tariff threats from the Trump administration. The $3bn site, which is ...

Virginia governor Glenn Youngkin noted that MSD’s $3bn commitment to the state marks a “giant leap forward for Virginia’s life sciences sector”. Image credit: rarrarorro via Shutterstock.com. Merck & ...

ST. LOUIS – From a hospital to housing complexes, some of our area’s largest institutions are behind on their utility bills. Thousands of account holders owe more than $100 million owed to the ...

The dynamic, innovative, and agile environment that is the pharmaceutical industry requires a particular set of skills. For MSD Ireland, one of the country’s largest healthcare companies with eight ...

US pharmaceutical giant Merck is scrapping a planned £1bn expansion of its UK operations, saying the government is not investing enough in the sector. The multi-national business, known as MSD in ...

Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. Pharmaceutical giant MSD is slashing $3bn ...